Skip to main content
Signal8

Landen Jaren

SEC insider (Form 3/4/5 filer). CIK 0002045287. Chief Clinical Dev. Officer at CASSAVA SCIENCES INC (SAVA). 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 18, 2024. Located in AUSTIN, TX.

Companies Landen Jaren has filed insider reports for

  • CASSAVA SCIENCES INC (SAVA): Officer, Chief Clinical Dev. Officer
Landen Jaren profile photo

Landen Jaren

CIK: 0002045287

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CASSAVA SCIENCES INC logo
SAVA

CASSAVA SCIENCES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • CASSAVA SCIENCES INC logo
    SAVA

    CASSAVA SCIENCES INC

    Nov 18, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    85K shares-

1-1 of 1